Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP, MSCs Secretome and HA for Knee Osteoarthritis
NCT05579665Phase 2Completed
- Sponsor
- Universitas Sriwijaya
- Start
- Oct 2022
- Primary completion
- Mar 2023
- Modality
- Polymer-based Nanoparticles, Adipose-derived MSCs, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of platelet-rich plasma, human umbilical cord mesenchymal stem cell secretome, hyaluronic acid in knee osteoarthritis (OA), sponsored by Universitas Sriwijaya. Started Oct 2022; status: completed.
02
Drugs
platelet-rich plasmahuman umbilical cord mesenchymal stem cell secretomehyaluronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05579665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05579665.